Simulations Plus, Inc. (NASDAQ:SLP – Free Report) – Equities research analysts at William Blair lowered their Q2 2025 EPS estimates for Simulations Plus in a report released on Wednesday, January 8th. William Blair analyst M. Smock now anticipates that the technology company will earn $0.22 per share for the quarter, down from their previous forecast of $0.27. William Blair has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.10 per share. William Blair also issued estimates for Simulations Plus’ Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.09 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.43 EPS and FY2026 earnings at $1.35 EPS.
Simulations Plus (NASDAQ:SLP – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. During the same period last year, the firm earned $0.18 EPS. The firm’s revenue for the quarter was up 19.9% on a year-over-year basis.
Check Out Our Latest Analysis on Simulations Plus
Simulations Plus Trading Up 0.1 %
Shares of SLP stock opened at $28.25 on Friday. Simulations Plus has a 12-month low of $24.00 and a 12-month high of $51.22. The company has a market cap of $567.40 million, a price-to-earnings ratio of 57.65 and a beta of 0.80. The stock has a 50 day simple moving average of $29.82 and a 200-day simple moving average of $33.82.
Insiders Place Their Bets
In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the transaction, the director now directly owns 3,442,584 shares of the company’s stock, valued at approximately $109,336,467.84. This represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 19.40% of the stock is currently owned by insiders.
Institutional Trading of Simulations Plus
A number of institutional investors and hedge funds have recently modified their holdings of the company. Arizona State Retirement System bought a new position in Simulations Plus during the second quarter valued at about $218,000. Los Angeles Capital Management LLC acquired a new stake in Simulations Plus in the second quarter worth about $206,000. Wedbush Securities Inc. grew its position in shares of Simulations Plus by 10.5% during the 2nd quarter. Wedbush Securities Inc. now owns 18,025 shares of the technology company’s stock worth $876,000 after buying an additional 1,709 shares during the period. Envestnet Asset Management Inc. lifted its holdings in Simulations Plus by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company’s stock valued at $2,665,000 after buying an additional 784 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after acquiring an additional 37,992 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Read More
- Five stocks we like better than Simulations Plus
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Dividend Kings To Consider
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is a Special Dividend?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.